Author Topic: Ibudilast receives fast track designation--studied for SPMS and PPMS (MSAA Research News)  (Read 383 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9821
  • MS diagnosed 1980
  • Location: Pacific Northwest
Looks as if ibudilast showed more dramatic results in PPMS than SPMS. Presented at the annual AAN conference (May 4-10, 2019), "Response to Treatment According to Progressive Disease Type: Analysis from a Phase II Progressive MS Trial of Ibudilast":


http://indexsmart.mirasmart.com/AAN2019/PDFfiles/AAN2019-002237.pdf
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
1 Replies
211 Views
Last post November 14, 2018, 04:04:14 pm
by agate
0 Replies
60 Views
Last post February 02, 2019, 03:59:52 pm
by agate
0 Replies
59 Views
Last post March 21, 2019, 04:33:52 pm
by agate
0 Replies
62 Views
Last post April 04, 2019, 04:14:29 pm
by agate
0 Replies
14 Views
Last post April 18, 2023, 09:42:30 pm
by agate